SecBot SecBot
144 ·Filed Apr 8, 2026

RCUS

Arcus Biosciences, Inc.
NEUTRAL
Impact 3/10
Horizonimmediate Processed7mo ago SEC0001950047-26-003313
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine insider transaction following option exercise; monitor for actual execution via Form 4 filing. Given the officer status, follow-through could signal confidence or simply portfolio management, context from future filings will clarify.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$23.28
T+0 close · Apr 8, 2026 · via day close
Latest settled
+28.78%
T+60 · $29.98
Vs SPY
+18.00%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 9 $23.28entry
  2. T+1 · 7mo ago −4.04%α −3.98% · $22.34
  3. T+5 · 7mo ago +1.33%α −1.85% · $23.59
  4. T+20 · 6mo ago +11.68%α +4.12% · $26.00
  5. T+60 · 4mo ago +28.78%α +18.00% · $29.98
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Jennifer Jarrett, an officer of Arcus Biosciences, filed a Form 144 to notify intent to sell 70,000 shares of common stock, valued at approximately $1.58 million based on current market prices. The shares were acquired via stock option exercise and the sale is planned on the NYSE.

Key Facts

  • Reporting person: Jennifer Jarrett, Officer
  • Number of shares intended for sale: 70,000
  • Approximate value of shares: $1,579,592 (based on $22.56/share)
  • Shares acquired via: Stock option exercise
  • Issuer: Arcus Biosciences, Inc. (RCUS)
  • Filing date: April 8, 2026
  • Planned transaction date: April 8, 2026
  • Broker: Morgan Stanley Smith Barney LLC

Financial Impact

70,000 shares worth ~$1.58 million, representing a small fraction of the company's $2.8B market cap

dilutioninsider ownership

Risk Factors

  • Potential downward pressure on stock if sale executes near-term
  • Perception of insider selling ahead of uncertain catalysts, though no such timing is indicated here

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-003313
Document: 0001950047-26-003313-index.html0001950047-26-003313
Document: 0001950047-26-003313.txt0001950047-26-003313

Track record

13 reports on RCUS

Performance horizon

2 of 4 bullish or bearish reports moved the stock their way by T+5. Best: +4.24% at T+1 after the Oct 21, 2026 report. 2 of 4 went positive at some point.

Filters
  1. Nov 16, 2026today Institutional Cluster Neutral 3/10 Entry $16.95 Now $16.86 −0.53% settles Nov 23
  2. Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Entry $18.95 to $16.86 Now $16.86 −11.03% ▼ −11.03% −9.34% vs SPY
  3. Nov 4, 202612d ago 8-K Neutral 5/10 Entry $17.69 to $17.77 Now $16.86 −4.69% ▲ +0.45% −2.84% vs SPY
  4. Oct 23, 202624d ago 8-K Bearish 5/10 Entry $17.76 to $18.19 Now $16.86 +5.07% ▼ −2.42% −3.68% vs SPY
  5. Oct 22, 202625d ago 424B5 Bearish 6/10 Entry $18.54 to $18.19 Now $16.86 +9.06% ▲ +1.89% +1.33% vs SPY
  6. Oct 21, 202626d ago 424B5 Bearish 5/10 Entry $19.36 to $18.61 Now $16.86 +12.91% ▲ +3.87% +4.58% vs SPY
  7. Oct 21, 202626d ago 8-K Neutral 4/10 Entry $19.36 to $18.61 Now $16.86 −12.91% ▼ −3.87% −4.58% vs SPY
  8. Oct 20, 202627d ago 8-K Neutral 4/10 Entry $23.75 to $18.14 Now $16.86 −29.01% ▼ −23.62% −23.70% vs SPY
  9. Jul 9, 202618w ago 144 Neutral 3/10 Entry $28.92 to $26.64 Now $16.86 −41.70% ▼ −7.88% −7.32% vs SPY
  10. Apr 21, 202629w ago DEFA14A Neutral 2/10 Entry $26.62 to $24.55 Now $16.86 −36.66% ▼ −7.79% −7.85% vs SPY
Showing 10 of 13

US Market Status

Market Closed · Opens in 6h 35m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 8, 2026